News
Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
4 Apr 24
Biotech, Large Cap, News, Health Care, Legal, Movers, Trading Ideas, General
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
4 Apr 24
Biotech, Health Care, Technicals, Top Stories, Trading Ideas, General
JMP Securities Reiterates Market Outperform on Arbutus Biopharma, Maintains $4 Price Target
4 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Arbutus Biopharma Announces Claim Construction Ruling In Ongoing Patent Infringement Lawsuit Against Moderna
4 Apr 24
News, Legal
Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
3 Apr 24
Health Care, Legal, Top Stories
Watching Arbutus Biopharma; Traders Circulate Arbutus/Genevant Vs Moderna Patent Infringement Lawsuit Claim Construction Order Court Documents
3 Apr 24
Biotech, News, Legal, General
Chardan Capital Reiterates Buy on Arbutus Biopharma, Maintains $4 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Arbutus Biopharma, Lowers Price Target to $5
1 Mar 24
News, Price Target, Analyst Ratings
Arbutus Biopharma Q4 EPS $(0.12), Inline, Sales $2.15M Miss $4.79M Estimate
29 Feb 24
Earnings, News
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Press releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
18 Apr 24
News, Press Releases
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
4 Apr 24
News, Legal, Press Releases, General
Arbutus to Participate in Two Upcoming Investor Conferences
8 Mar 24
News, Press Releases
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
29 Feb 24
Earnings, Press Releases
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
15 Feb 24
News, Press Releases